Table 1.
Demographic and clinical characteristics as well as associations with sleep disturbance (WCHSF, 2012 – 2019).
| Participant Characteristics (n=637) |
Number (%) with Clinically-Significant Sleep Disturbance | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-Diagnosis (n=637) |
10 Months post-Dx (n=261) |
24 Months post-Dx (n=632) |
||||||||
| n (%) | Yes | No | P | Yes | No | P | Yes | No | P | |
| Age (years) | .19 | .63 | <.01 | |||||||
| <50 | 191 (30) | 117(32) | 74 (27) | 47 (34) | 35 (29) | 128(33) | 68 (27) | |||
| 50–60 | 192(30) | 114(31) | 78 (29) | 42 (30) | 37 (30) | 138(36) | 68 (27) | |||
| >60 | 254 (40) | 135(37) | 119(44) | 50 (36) | 50(41) | 119(31) | 111 (45) | |||
| Education | <.01 | .10 | 054 | |||||||
| < High School | 205 (32) | 117(32) | 88 (33) | 48 (35) | 28 (23) | 146 (38) | 75 (30) | |||
| Some college | 220 (35) | 146 (40) | 74 (27) | 49 (35) | 46 (38) | 131 (34) | 82 (33) | |||
| College or Grad Degree | 212(33) | 103(28) | 109(40) | 42 (30) | 48 (39) | 108(28) | 90 (37) | |||
| Marital Status | .36 | .31 | .09 | |||||||
| Not married | 393 (62) | 231 (63) | 162 (60) | 88 (63) | 69 (57) | 261 (68) | 151 (61) | |||
| Married | 242 (38) | 133(37) | 109(40) | 51 (37) | 53 (43) | 124(32) | 96 (39) | |||
| Annual Household Income | .10 | .89 | .03 | |||||||
| < $25,000 | 176(30) | 112(33) | 64 (26) | 37 (28) | 30 (27) | 136(37) | 63 (27) | |||
| $25,000 – $69,000 | 214(37) | 113(33) | 101 (41) | 48 (36) | 44 (39) | 120(33) | 89 (38) | |||
| > $70,000 | 194(33) | 113(33) | 81 (33) | 49 (36) | 39 (34) | 110(30) | 84 (35) | |||
| Insurance Status | .52 | .03 | .08 | |||||||
| None | 61 (10) | 35(10) | 26(10) | 23(17) | 9(7) | 44(11) | 18(7) | |||
| Medicaid | 76(12) | 49(13) | 27(10) | 10(7) | 18(15) | 48(13) | 20(8) | |||
| Medicare | 119(19) | 64(18) | 55 (20) | 20 (14) | 24 (20) | 66(17) | 48 (20) | |||
| Private/Other | 374 (59) | 212 (59) | 162 (60) | 85 (62) | 71 (58) | 224 (59) | 160(65) | |||
| Smoking Status | .15 | .92 | .17 | |||||||
| Never | 372 (58) | 209 (57) | 163 (60) | 87 (63) | 74(61) | 237 (62) | 140(57) | |||
| Former | 162 (26) | 89 (24) | 73 (27) | 35 (25) | 31 (25) | 85 (22) | 71 (29) | |||
| Current | 103(16) | 68(19) | 35(13) | 17(12) | 17(14) | 63(16) | 36 (14) | |||
| Menopausal Status | .35 | .61 | .07 | |||||||
| Premenopausal | 220 (35) | 132(36) | 88 (33) | 53 (38) | 42 (34) | 141 (37) | 73 (30) | |||
| Postmenopausal | 413(65) | 231 (64) | 182(67) | 86 (62) | 80 (66) | 242 (63) | 174(70) | |||
| Pre-Diagnostic BMI (Kg/m2) | .13 | .14 | .09 | |||||||
| <25 | 86(13) | 44 (12) | 42 (16) | 14(10) | 21 (17) | 57(15) | 40(16) | |||
| 25–29 | 189(30) | 102(28) | 87 (32) | 41 (30) | 40 (33) | 94 (24) | 78 (32) | |||
| >30 | 360 (57) | 219(60) | 141 (52) | 84 (60) | 61 (50) | 233(61) | 129(52) | |||
| 24 Months Post-Diagnosis BMI | .51 | .46 | .03 | |||||||
| <25 | 47(14) | 25 (12) | 22(16) | 8(10) | 12(18) | 51 (13) | 36(15) | |||
| 25–29 | 90 (27) | 53 (26) | 37 (28) | 22 (28) | 18(26) | 94 (25) | 82 (33) | |||
| >30 | 201 (59) | 125 (62) | 76 (56) | 48 (62) | 38 (56) | 237 (62) | 128(52) | |||
| Pre-Diagnostic Type 2 Diabetes | .70 | .88 | >.99 | |||||||
| No | 495 (78) | 282 (77) | 213(79) | 111 (80) | 99(81) | 298 (78) | 192(78) | |||
| Yes | 142(22) | 84 (23) | 58 (21) | 28 (20) | 23(19) | 86 (22) | 55 (22) | |||
| Pre-Diagnostic Hypertension | .51 | >.99 | .80 | |||||||
| No | 243 (38) | 144 (39) | 99 (37) | 86 (62) | 75(61) | 155(40) | 102(41) | |||
| Yes | 394 (62) | 222(61) | 172(63) | 53 (38) | 47 (39) | 230 (60) | 145(59) | |||
| AJCC Stage | ||||||||||
| 0 | 120(23) | 72 (24) | 48 (22) | .85 | 25 (20) | 32 (28) | .26 | 71 (20) | 58 (26) | .19 |
| I/II | 363 (70) | 206 (69) | 157(71) | 90 (70) | 75 (65) | 256(71) | 152(67) | |||
| III/IV | 35(7) | 20(7) | 15(7) | 13(10) | 8(7) | 32(9) | 15(7) | |||
| Surgery Type | .76 | .10 | .09 | |||||||
| None | 46(7) | 28(8) | 18(7) | 14(10) | 10(8) | 24(6) | 19(8) | |||
| Lumpectomy | 421 (66) | 237 (65) | 184(68) | 83 (60) | 88 (72) | 240 (62) | 169(69) | |||
| Mastectomy | 168(27) | 99 (27) | 69 (25) | 42 (30) | 24 (20) | 121 (32) | 58 (23) | |||
| Treated with Chemotherapy | .63 | .01 | .06 | |||||||
| No | 311 (49) | 175(48) | 136(50) | 58 (42) | 72 (59) | 180(47) | 134(54) | |||
| Yes | 324(51) | 189(52) | 135(50) | 81 (58) | 50(41) | 205 (53) | 112(46) | |||
| Treated with Radiotherapy | .80 | .53 | .19 | |||||||
| No | 223 (35) | 126(35) | 97 (36) | 59 (42) | 46 (38) | 171 (44) | 95 (39) | |||
| Yes | 411 (65) | 237 (65) | 174(64) | 80 (58) | 75 (62) | 214(56) | 150(61) | |||
| Treated with Endocrine Therapy | .57 | .02 | .33 | |||||||
| No | 295 (47) | 173(48) | 122(45) | 81 (59) | 53 (44) | 188(49) | 110(45) | |||
| Yes | 338 (53) | 190(52) | 148 (55) | 57(41) | 68 (56) | 196(51) | 135(55) | |||
| .Lymphedema at 24 Months | .26 | .39 | <.01 | |||||||
| No | 616(97) | 351 (96) | 265 (98) | 131 (94) | 118(97) | 348 (90) | 240 (97) | |||
| Yes | 21(3) | 15(4) | 6(2) | 8(6) | 4(3) | 37(10) | 7(3) | |||
Note: Some categories do not add up to N=637, n=261, or n=632 due to missing data. Clinically-significant sleep disturbance was defined as having a Pittsburgh Sleep Quality Index score of ≥ 5.29 Treatment information is based on participant self-report.